☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Combinations
Chi-Med and BeiGene Collaborate to Evaluate the Combinations of Surufatinib and Fruquintinib with Tislelizumab for Solid Tumors
May 26, 2020
Load more...
Back to Home